Use access key #2 to skip to page content.
$3.34 -0.01 (-0.30%)
10/7/2008 12:00 PM

Nektar Therapeutics (NKTR)

CAPS Rating:
**

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.

View All Commentary (NKTR)

Recs

0

Avatar Aiden1976 (89.37) Submitted: 4/09/08 12:32 PM : Outperform Start Price: $5.06 NKTR Score: -11.36

Because Pfizer want to stop sell the product(inulin inhaler) with NKTR, and the stock got plunge down hard by about 25%. But it will search for another partner to continue sell the product. It might be down for awhile, but I will come back up.

Report this Post Replies: 0 | Reply

Featured Broker Partners